mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
TL-2-105 |
GDSC1000 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
C6-ceramide |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
COL-3 |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
ML320 |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
BI-2536 |
GDSC1000 |
pan-cancer |
AAC |
-0.028 |
0.6 |
mRNA |
KIN001-244 |
GDSC1000 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
erismodegib |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |